Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
SION
Sionna Therapeutics, Inc.
CAPPED RATING
Sionna Therapeutics, Inc. (SION) is rated C (2.3/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B+); its weakest is Momentum (D-).
Quantitative Factor Evaluation • Updated
Overall Rating
2.3
/ 5.0
C
Value
B+
Factor Score
3.7
/ 5.0
Growth
C-
Factor Score
2.0
/ 5.0
Profitability
C-
Factor Score
2.0
/ 5.0
Momentum
D-
Factor Score
1.0
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
-1.5
EV / EBITDA
0.5
Rev Growth YoY
N/A
Gross Margin
0.0%
Price Return 3M
-43.6%
Price Return 12M
-90.9%
Catalyst Signal
0.00
Market Cap
$150.6M
TTM Revenue
N/A
Price / Sales
N/A
ROE
-39.0%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-14 | B+ (3.7) | C- (2.0) | C- (2.0) | D- (1.0) | C+ (2.6) | C (2.3) |
| 2026-11-07 | B+ (3.8) | C- (2.0) | C- (2.0) | D (1.4) | F (0.0) | D+ (1.8) |
| 2026-10-31 | B+ (3.7) | C- (1.9) | C- (2.0) | F (0.3) | F (0.0) | D+ (1.6) |
| 2026-10-24 | B+ (3.7) | C- (1.9) | C- (2.0) | F (0.3) | F (0.0) | D+ (1.6) |
| 2026-10-17 | B+ (3.7) | C- (1.9) | C- (2.0) | F (0.4) | F (0.0) | D+ (1.6) |
Page
1
of
4